{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:26:05Z","timestamp":1793316365165,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T00:00:00Z","timestamp":1697760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81861138044"],"award-info":[{"award-number":["81861138044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172256"],"award-info":[{"award-number":["82172256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92169105"],"award-info":[{"award-number":["92169105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["M-0060"],"award-info":[{"award-number":["M-0060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2017ZX10202203"],"award-info":[{"award-number":["2017ZX10202203"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.virs.2023.10.007","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:33:23Z","timestamp":1697848403000},"page":"851-859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Recent advances in understanding T cell activation and exhaustion during HBV infection"],"prefix":"10.1016","volume":"38","author":[{"given":"Lu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zida","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2023.10.007_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.virs.2023.10.007_bib2","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1136\/gutjnl-2021-324646","article-title":"Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection","volume":"71","author":"Aliabadi","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.virs.2023.10.007_bib3","doi-asserted-by":"crossref","first-page":"9652","DOI":"10.1128\/JVI.00867-09","article-title":"The size of the viral inoculum contributes to the outcome of hepatitis B virus infection","volume":"83","author":"Asabe","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2023.10.007_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2567.2003.01699.x","article-title":"Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape","volume":"109","author":"Beckebaum","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.virs.2023.10.007_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41586-019-1620-6","article-title":"Dynamics and genomic landscape of CD8(+) T cells undergoing hepatic priming","volume":"574","author":"Benechet","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.virs.2023.10.007_bib6","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","article-title":"Adaptive immunity in HBV infection","volume":"64","author":"Bertoletti","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.10.007_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/j.gastro.2007.11.002","article-title":"T\u00a0cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes","volume":"134","author":"Bohne","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virs.2023.10.007_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/14712598.2017.1265940","article-title":"Present and future DNA vaccines for chronic hepatitis B treatment","volume":"17","author":"Cova","year":"2017","journal-title":"Expet Opin. Biol. Ther."},{"key":"10.1016\/j.virs.2023.10.007_bib9","doi-asserted-by":"crossref","first-page":"887408","DOI":"10.3389\/fmicb.2022.887408","article-title":"Immune Checkpoint Molecules Expressed on CD4(+) T Cell Subsets in Chronic Asymptomatic Hepatitis B Virus Carriers With Hepatitis B e Antigen-Negative","volume":"13","author":"Cui","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virs.2023.10.007_bib10","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.immuni.2021.05.005","article-title":"Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming","volume":"54","author":"De Simone","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2023.10.007_bib11","doi-asserted-by":"crossref","first-page":"117663","DOI":"10.1016\/j.lfs.2020.117663","article-title":"JAK\/STAT signaling is involved in IL-35-induced inhibition of hepatitis B virus antigen-specific cytotoxic T cell exhaustion in chronic hepatitis B","volume":"252","author":"Dong","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.virs.2023.10.007_bib12","doi-asserted-by":"crossref","first-page":"641362","DOI":"10.3389\/fimmu.2021.641362","article-title":"Increased circulating T follicular helper cells induced via IL-12\/21 in patients with acute on chronic hepatitis B liver failure","volume":"12","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virs.2023.10.007_bib14","doi-asserted-by":"crossref","first-page":"648420","DOI":"10.3389\/fimmu.2021.648420","article-title":"Functional exhaustion of HBV-specific CD8 T cells impedes PD-L1 blockade efficacy in chronic HBV infection","volume":"12","author":"Ferrando-Martinez","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib15","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","article-title":"Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches","volume":"11","author":"Fisicaro","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","author":"Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virs.2023.10.007_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi6112","article-title":"Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability","volume":"7","author":"Fumagalli","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.virs.2023.10.007_bib18","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","article-title":"Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: a pilot study","volume":"71","author":"Gane","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.10.007_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2094","article-title":"Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: implications for therapeutic monitoring and personalized therapy","volume":"30","author":"Hakim","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.virs.2023.10.007_bib20","first-page":"1","article-title":"TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection","volume":"0","author":"Heim","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.virs.2023.10.007_bib21","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2022.05.041","article-title":"Hepatitis B virus-specific CD4 T cell responses differentiate functional cure from chronic surface antigen(+) infection","volume":"77","author":"Hoogeveen","year":"2022","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.10.007_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gutjnl-2018-316644","article-title":"Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection","volume":"68","author":"Hoogeveen","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.virs.2023.10.007_bib23","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.1700921","article-title":"Local stimulation of liver sinusoidal endothelial cells with a NOD1 agonist activates T cells and suppresses hepatitis B virus replication in mice","volume":"200","author":"Huang","year":"2018","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib25","doi-asserted-by":"crossref","first-page":"11740","DOI":"10.3390\/ijms231911740","article-title":"Cytokine storm-definition, causes, and implications","volume":"23","author":"Jarczak","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virs.2023.10.007_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.virs.2023.10.007_bib27","doi-asserted-by":"crossref","first-page":"599648","DOI":"10.3389\/fimmu.2020.599648","article-title":"IL-21-Deficient T follicular helper cells support B cell responses through IL-27 in patients with chronic hepatitis B","volume":"11","author":"Khanam","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib28","doi-asserted-by":"crossref","first-page":"734246","DOI":"10.3389\/fimmu.2021.734246","article-title":"Depletion of T cells via inducible caspase 9 increases safety of adoptive T-cell therapy against chronic hepatitis B","volume":"12","author":"Klopp","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib29","article-title":"Immunogenicity and antiviral response of therapeutic hepatitis B vaccination in a mouse model of HBeAg-negative","volume":"9","author":"Kosinska","year":"2021"},{"key":"10.1016\/j.virs.2023.10.007_bib30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2013.04.047","article-title":"T\u00a0cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice","volume":"145","author":"Krebs","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virs.2023.10.007_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jcyt.2018.02.002","article-title":"HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice","volume":"20","author":"Kruse","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.virs.2023.10.007_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2023.10.007_bib33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2020.04.019","article-title":"Effects of hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection","volume":"159","author":"Le Bert","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virs.2023.10.007_bib34","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2021.07.027","article-title":"Antibody-mediated rejection of the liver allograft: an update and a clinico-pathological perspective","volume":"75","author":"Lee","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.10.007_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/vim.2021.0140","article-title":"Interleukin-33 reinvigorates antiviral function of viral-specific CD8(+) T cells in chronic hepatitis B virus infection","volume":"35","author":"Li","year":"2022","journal-title":"Viral Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib36","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2019.09.031","article-title":"CXCL13-mediated recruitment of intrahepatic CXCR5(+)CD8(+) T cells favors viral control in chronic HBV infection","volume":"72","author":"Li","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.10.007_bib37","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/MCG.0000000000001461","article-title":"Phenotypic changes of PD-1 and GITR in T cells are associated with hepatitis B surface antigen seroclearance","volume":"56","author":"Liu","year":"2022","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.virs.2023.10.007_bib38","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.4049\/jimmunol.1301262","article-title":"TLR1\/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro","volume":"191","author":"Liu","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003856","article-title":"Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection","volume":"10","author":"Liu","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2023.10.007_bib40","doi-asserted-by":"crossref","first-page":"884290","DOI":"10.3389\/fimmu.2022.884290","article-title":"Natural killer cells induce CD8(+) T cell dysfunction via galectin-9\/TIM-3 in chronic hepatitis B virus infection","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib41","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00262-019-02426-5","article-title":"PD-1(+) TIGIT(+) CD8(+) T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma","volume":"68","author":"Liu","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.virs.2023.10.007_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/vim.2021.0164","article-title":"Interleukin-18 plays a positive feedback activity to natural killer-like B cells in hepatitis B virus-associated acute-on-chronic liver failure","volume":"35","author":"Liu","year":"2022","journal-title":"Viral Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib43","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1016\/j.jhep.2015.01.018","article-title":"Strategies to control hepatitis B: public policy, epidemiology, vaccine and drugs","volume":"62","author":"Locarnini","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.10.007_bib44","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jhep.2016.05.016","article-title":"Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B","volume":"65","author":"Lok","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.10.007_bib45","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3389\/fimmu.2018.01561","article-title":"Hepatitis B virus adaptation to the CD8+ T cell response: consequences for host and pathogen","volume":"9","author":"Lumley","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1084\/jem.20120994","article-title":"The origins, function, and regulation of T follicular helper cells","volume":"209","author":"Ma","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.virs.2023.10.007_bib47","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib48","doi-asserted-by":"crossref","first-page":"663201","DOI":"10.3389\/fimmu.2021.663201","article-title":"Reactions related to CAR-T cell therapy","volume":"12","author":"Miao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib49","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2020.01.032","article-title":"Knockdown of virus antigen expression increases therapeutic vaccine efficacy in high-titer hepatitis B virus carrier mice","volume":"158","author":"Michler","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virs.2023.10.007_bib50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.micpath.2019.01.026","article-title":"TIM-3 as a marker of exhaustion in CD8(+) T cells of active chronic hepatitis B patients","volume":"128","author":"Mohammadizad","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.virs.2023.10.007_bib51","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jvh.13731","article-title":"Hepatitis B e antigen and e antibody in a multi-ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years","volume":"29","author":"Mutimer","year":"2022","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.virs.2023.10.007_bib52","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.32331","article-title":"Diverse facets of MDSC in different phases of chronic HBV infection: impact on HBV-specific T-cell response and homing","volume":"76","author":"Pal","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.virs.2023.10.007_bib53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3856","article-title":"Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells","volume":"21","author":"Pallett","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2023.10.007_bib54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib55","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.23936","article-title":"The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function","volume":"52","author":"Raziorrouh","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.virs.2023.10.007_bib56","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1172\/JCI92812","article-title":"Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation","volume":"128","author":"Rivino","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.virs.2023.10.007_bib57","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3389\/fimmu.2020.02155","article-title":"The immunological basis of liver allograft rejection","volume":"11","author":"Ronca","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib58","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.virs.2023.10.007_bib59","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/s41467-021-22967-7","article-title":"Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpoint","volume":"12","author":"Schmidt","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2023.10.007_bib60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.annonc.2020.10.478","article-title":"Side-effect management of chimeric antigen receptor (CAR) T-cell therapy","volume":"32","author":"Schubert","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.virs.2023.10.007_bib61","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gutjnl-2018-316641","article-title":"Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load","volume":"68","author":"Schuch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.virs.2023.10.007_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003208","article-title":"The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells","volume":"9","author":"Schurich","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2023.10.007_bib63","doi-asserted-by":"crossref","first-page":"eaba7918","DOI":"10.1126\/sciimmunol.aba7918","article-title":"TOX is expressed by exhausted and polyfunctional human effector memory CD8(+) T cells","volume":"5","author":"Sekine","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.virs.2023.10.007_bib64","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.trecan.2022.06.008","article-title":"Therapeutic targeting of regulatory T cells in cancer","volume":"8","author":"Shan","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.virs.2023.10.007_bib65","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fcimb.2017.00472","article-title":"Interleukin-35 suppresses antiviral immune response in chronic hepatitis B virus infection","volume":"7","author":"Shao","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virs.2023.10.007_bib66","doi-asserted-by":"crossref","first-page":"105076","DOI":"10.1016\/j.antiviral.2021.105076","article-title":"Prior transient exposure to interleukin-21 delivered by recombinant adeno-associated virus vector protects mice from hepatitis B virus persistence","volume":"190","author":"Shen","year":"2021","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2023.10.007_bib67","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.7150\/thno.35331","article-title":"IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse models","volume":"9","author":"Shen","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.virs.2023.10.007_bib68","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2022.12.013","article-title":"Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models","volume":"78","author":"Su","year":"2023","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.10.007_bib69","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/hep4.1857","article-title":"Immunological alterations after immunotherapy with short lived HBV-TCR T cells associates with long-term treatment response in HBV-HCC","volume":"6","author":"Tan","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.virs.2023.10.007_bib70","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/infdis\/jiy576","article-title":"Interleukin 21 reinvigorates the antiviral activity of hepatitis B virus (HBV)-Specific CD8+ T cells in chronic HBV infection","volume":"219","author":"Tang","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.virs.2023.10.007_bib71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2023.10.007_bib72","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/2159-8290.CD-20-0756","article-title":"A\u00a0critical role for fas-mediated off-target tumor killing in T-cell immunotherapy","volume":"11","author":"Upadhyay","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.virs.2023.10.007_bib73","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41392-021-00776-0","article-title":"Restoration of HBV-specific CD8(+) T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-alpha therapy","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virs.2023.10.007_bib74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fimmu.2018.00219","article-title":"Hepatitis B virus-specific CD8+ T cells maintain functional exhaustion after antigen reexposure in an acute activation immune environment","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib75","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1053\/j.gastro.2018.03.021","article-title":"Dysregulated response of follicular helper T cells to hepatitis B surface antigen promotes HBV persistence in mice and associates with outcomes of patients","volume":"154","author":"Wang","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virs.2023.10.007_bib76","first-page":"942","article-title":"TIGIT marks exhausted T cells and serves as a target for immune restoration in patients with chronic HBV infection","volume":"14","author":"Wei","year":"2022","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.virs.2023.10.007_bib77","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T\u00a0cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib78","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib79","unstructured":"WHO, 2023. In: World Health Statistics 2023: Monitoring Health for the SDGs, Sustainable Development Goals, 4. World Health Organization, Geneva, https:\/\/www.who.int\/publications\/i\/item\/9789240074323. (Accessed June 4 2023)"},{"key":"10.1016\/j.virs.2023.10.007_bib80","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1038\/s41423-021-00769-7","article-title":"HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance","volume":"18","author":"Xie","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib81","doi-asserted-by":"crossref","first-page":"797915","DOI":"10.3389\/fcimb.2022.797915","article-title":"HBeAg is indispensable for inducing liver sinusoidal endothelial cell activation by hepatitis B virus","volume":"12","author":"Xie","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virs.2023.10.007_bib82","doi-asserted-by":"crossref","first-page":"103464","DOI":"10.1016\/j.ebiom.2021.103464","article-title":"Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss","volume":"69","author":"Xiong","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virs.2023.10.007_bib83","doi-asserted-by":"crossref","first-page":"104663","DOI":"10.1016\/j.meegid.2020.104663","article-title":"Human genetic susceptibility to hepatitis B virus infection","volume":"87","author":"Xu","year":"2021","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.virs.2023.10.007_bib84","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2019.05.013","article-title":"MMP2\/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance","volume":"71","author":"Yang","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.virs.2023.10.007_bib85","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fimmu.2018.00472","article-title":"Hyper-expression of PD-1 is associated with the levels of exhausted and dysfunctional phenotypes of circulating CD161(++)TCR iValpha7.2(+) mucosal-associated invariant T cells in chronic hepatitis B virus infection","volume":"9","author":"Yong","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2023.10.007_bib86","doi-asserted-by":"crossref","first-page":"850665","DOI":"10.3389\/fmicb.2022.850665","article-title":"Hepatitis B virus-specific cellular immunity contributes to the outcome of occult hepatitis B virus infection","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virs.2023.10.007_bib87","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.2147\/IJN.S317113","article-title":"Chitosan nanovaccines as efficient carrier adjuvant system for IL-12 with enhanced protection against HBV","volume":"16","author":"Zhao","year":"2021","journal-title":"Int. J. Nanomed."}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X2300130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X2300130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:20:21Z","timestamp":1761852021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X2300130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1995820X2300130X"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2023.10.007","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in understanding T cell activation and exhaustion during HBV infection","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2023.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}